Randomized Trial of Short-Course High-Dose Erythropoietin in Donation After Cardiac Death Kidney Transplant Recipients
American Journal of Transplantation, 04/18/2012Aydin Z et al.
Results showed no differences in the incidence or duration of delayed graft function and/or primary nonfunction. Epoetin treatment significantly increased the risk of thrombotic events at 1 month and 1 year.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.